How Vasculitis Causes Hemorrhagic Stroke
Vasculitis causes hemorrhagic stroke through necrotizing inflammation of vessel walls that leads to vascular dilatation, aneurysm formation, and vessel wall rupture, resulting in bleeding into brain tissue. 1
Pathophysiologic Mechanism
The fundamental process involves necrotizing inflammation of small and medium-sized blood vessels that damages the structural integrity of vessel walls through several mechanisms:
Direct Vessel Wall Damage
- Necrotizing vasculitis destroys the vessel wall architecture, creating areas of weakness that can rupture 2
- The inflammatory process causes both stenosis (narrowing) and dilatation of vessels
- Vessel wall friability increases dramatically, making vessels prone to spontaneous rupture 3
- This dual pathology explains why patients can experience both ischemic and hemorrhagic strokes simultaneously 2
Specific Vascular Changes
The vasculitic process produces:
- Aneurysmal dilatation of weakened vessel segments that can rupture 1
- Loss of normal vessel wall elasticity and structural support
- Inflammatory infiltration that compromises vessel integrity 4
Clinical Context and Risk Factors
Types of Vasculitis Most Commonly Involved
ANCA-associated vasculitides (granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis) are the primary culprits 5, 2. These conditions:
- Affect small vessels (arterioles, capillaries, venules) predominantly
- Can occasionally involve medium or large vessels
- Are characterized by pauci-immune necrotizing inflammation
Important Clinical Pitfall
Patients with active vasculitis are at markedly increased risk of hemorrhagic transformation when given thrombolytics (IV tPA) for ischemic stroke 6. The damaged, friable vessel walls cannot withstand the effects of thrombolytic therapy, leading to catastrophic intracerebral hemorrhage. Some experts suggest AAV should be considered a contraindication to IV tPA administration 6.
Diagnostic Considerations
When vasculitis-related hemorrhagic stroke is suspected, look for:
- Systemic symptoms: fever, weight loss, elevated inflammatory markers (ESR, CRP)
- Multi-organ involvement: kidney disease (hematuria, proteinuria, rising creatinine), pulmonary hemorrhage, peripheral neuropathy, skin lesions 5
- ANCA positivity (MPO or PR3 antibodies) in approximately 90% of cases 5
- Imaging findings: multiple vascular territories affected, evidence of both stenosis and dilatation on angiography 7
Critical Warning
Hemorrhagic stroke can occur simultaneously with ischemic stroke in vasculitis patients due to the mixed pathology of vessel stenosis and rupture 2. Exercise extreme caution with antiplatelet or anticoagulation therapy in these patients.
Treatment Implications
The hemorrhagic complication underscores the need for:
- Aggressive immunosuppression with high-dose glucocorticoids plus cyclophosphamide or rituximab 5
- Urgent treatment initiation once vasculitis is diagnosed to prevent further vascular damage
- Avoidance of thrombolytics in patients with known or suspected active vasculitis 6
- Multidisciplinary management in expert centers given the complexity and rarity of these conditions 7
The key distinction from other causes of hemorrhagic stroke is that vasculitis produces active, ongoing vessel wall destruction rather than chronic structural abnormalities, making prompt immunosuppressive therapy essential to halt the inflammatory process and prevent recurrent hemorrhagic or ischemic events.